These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 7521963)
1. Maternal serum inhibin levels in second-trimester Down's syndrome pregnancies. Cuckle HS; Holding S; Jones R Prenat Diagn; 1994 May; 14(5):387-90. PubMed ID: 7521963 [TBL] [Abstract][Full Text] [Related]
2. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869 [TBL] [Abstract][Full Text] [Related]
3. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome. Cuckle HS; Holding S; Jones R; Groome NP; Wallace EM Prenat Diagn; 1996 Dec; 16(12):1095-100. PubMed ID: 8994244 [TBL] [Abstract][Full Text] [Related]
4. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy. Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718 [TBL] [Abstract][Full Text] [Related]
7. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol. Extermann P; Bischof P; Marguerat P; Mermillod B Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261 [TBL] [Abstract][Full Text] [Related]
8. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters. Wald NJ; Watt HC; Hackshaw AK N Engl J Med; 1999 Aug; 341(7):461-7. PubMed ID: 10441601 [TBL] [Abstract][Full Text] [Related]
9. Second trimester maternal dimeric inhibin-A in the multiple-marker screening test for Down's syndrome. Renier MA; Vereecken A; Van Herck E; Straetmans D; Ramaekers P; Buytaert P Hum Reprod; 1998 Mar; 13(3):744-8. PubMed ID: 9572446 [TBL] [Abstract][Full Text] [Related]
10. Dimeric inhibin A as a fourth marker for Down's syndrome maternal serum screening in native Japanese women. Yoshida K; Kuwabara Y; Tanaka T; Onda T; Kudo R; Yamamoto H; Sato A; Yanagida K; Okai T; Sakai M; Takai Y; Uemura H; Hoshi K; Fukada Y; Aono T; Maeda K; Ogita S; Ishiko O; Murata Y; Kanzaki T; Myrick F; Grier RE J Obstet Gynaecol Res; 2000 Jun; 26(3):171-4. PubMed ID: 10932977 [TBL] [Abstract][Full Text] [Related]
11. First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening. Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012599. PubMed ID: 28295159 [TBL] [Abstract][Full Text] [Related]
12. Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy. Lambert-Messerlian GM; Canick JA; Palomaki GE; Schneyer AL J Med Screen; 1996; 3(2):58-62. PubMed ID: 8849760 [TBL] [Abstract][Full Text] [Related]
13. Maternal serum inhibin-A levels in twin pregnancies: implications for screening for Down's syndrome. Watt HC; Wald NJ; George L Prenat Diagn; 1996 Oct; 16(10):927-9. PubMed ID: 8938062 [TBL] [Abstract][Full Text] [Related]
14. Maternal serum inhibin-A in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome. Wald NJ; Watt HC; George L Prenat Diagn; 1996 Oct; 16(10):923-6. PubMed ID: 8938061 [TBL] [Abstract][Full Text] [Related]
15. Serum markers for Down's syndrome in relation to number of previous births and maternal age. Wald NJ; Watt HC Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278 [TBL] [Abstract][Full Text] [Related]
16. Effect of allowing for ethnic group in prenatal screening for Down's syndrome. Watt HC; Wald NJ; Smith D; Kennard A; Densem J Prenat Diagn; 1996 Aug; 16(8):691-8. PubMed ID: 8878277 [TBL] [Abstract][Full Text] [Related]
17. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group. Wald NJ; George L; Smith D; Densem JW; Petterson K Br J Obstet Gynaecol; 1996 May; 103(5):407-12. PubMed ID: 8624312 [TBL] [Abstract][Full Text] [Related]
18. Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome. Wald NJ; Cuckle HS; Densem JW; Nanchahal K; Canick JA; Haddow JE; Knight GJ; Palomaki GE Br J Obstet Gynaecol; 1988 Apr; 95(4):334-41. PubMed ID: 2454652 [TBL] [Abstract][Full Text] [Related]
19. Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme. Goodburn SF; Yates JR; Raggatt PR; Carr C; Ferguson-Smith ME; Kershaw AJ; Milton PJ; Ferguson-Smith MA Prenat Diagn; 1994 May; 14(5):391-402. PubMed ID: 7521964 [TBL] [Abstract][Full Text] [Related]